Therapeutic uses of tigemonam and carumonam
作者： Olga Rodny
DOI:
关键词:
摘要: Disclosed herein is the use of tigemonam and carumonam in treating bacterial infection caused by bacteria producing K. pneumoniae carbapenemase (KPC) enzymes.
lens.org 参考文章(8)
Olga Lomovskaya, Michael N. Dudley, Jeffrey S. Loutit, David C. Griffith, Methods of treating bacterial infections ,(2016)
Gopalan Balasubramanian, Senthilkumar Udayampalayam Palanisamy, Shridhar Narayanan, Maneesh Paul-Satyaseela, Hariharan Periasamy, Senthilnathan Manickam, Aravind Appu, Compounds and their use ,(2011)
S K Tanaka, R A Summerill, B F Minassian, K Bush, D A Visnic, D P Bonner, R B Sykes, In vivo evaluation of tigemonam, a novel oral monobactam. Antimicrobial Agents and Chemotherapy. ,vol. 31, pp. 219- 225 ,(1987) , 10.1128/AAC.31.2.219
Maria Virginia Villegas, Karen Lolans, Adriana Correa, Juan Nicolas Kattan, Jaime A. Lopez, John P. Quinn, First Identification of Pseudomonas aeruginosa Isolates Producing a KPC-Type Carbapenem-Hydrolyzing β-Lactamase Antimicrobial Agents and Chemotherapy. ,vol. 51, pp. 1553- 1555 ,(2007) , 10.1128/AAC.01405-06
P. A. Bradford, S. Bratu, C. Urban, M. Visalli, N. Mariano, D. Landman, J. J. Rahal, S. Brooks, S. Cebular, J. Quale, Emergence of Carbapenem-Resistant Klebsiella Species Possessing the Class A Carbapenem-Hydrolyzing KPC-2 and Inhibitor-Resistant TEM-30 β-Lactamases in New York City Clinical Infectious Diseases. ,vol. 39, pp. 55- 60 ,(2004) , 10.1086/421495
D. M. Livermore, Has the era of untreatable infections arrived Journal of Antimicrobial Chemotherapy. ,vol. 64, ,(2009) , 10.1093/JAC/DKP255
Bérangère Gaucher, Patrick Roussel, Eric Desarbre, Malcolm G. P. Page, Useful combinations of monobactam antibiotics with beta-lactamase inhibitors ,(2006)
Ning Yin, Dylan C. Alexander, Yu Gui Gu, Yong He, Jason B. Cross, Chester A. Metcalf, Robert Busch, 1,2,4-oxadiazole and 1,2,4-thiadiazole beta-lactamase inhibitors ,(2013)